论文部分内容阅读
Cancer immunotherapy is offering great clinical advances,in some cases providing stunning clinical outcomes.CAR-T and checkpoint inhibitors have yielded great insights into the mechanisms by which cancer tissues evade the immune system by inhibiting immune cell activation.